Obesity and hypothyroidism are both common disorders within the general population. Obese hypothyroid subjects require higher doses of levothyroxine (LT4) compared with normal weight individuals. Previous studies on the effects of bariatric surgery on LT4 dose requirements in hypothyroid subjects have provided conflicting results. The aim of this study was to evaluate the LT4 requirements in a group of obese subjects with acquired hypothyroidism, before and after weight loss achieved by bariatric surgery
BACKGROUND: The aim of this study was to evaluate the effect of bariatric surgery on the defined dai...
Objective: Levothyroxine (LT4) is used by almost 13 million patients in USA and in the same country ...
The most common endocrine disease in obesity is hypothyroidism and secondary endocrine alterations, ...
Aim: Levothyroxine (L-T4) requirements in obese hypothyroid patients receiving L-T4 therapy decrease...
The most frequent endocrine disease in obese patients is hypothyroidism. To date, there are no clear...
Aim: Levothyroxine (L-T4) requirements in obese hypothyroid patients receiving L-T4 therapy decrease...
Levothyroxine (LT4) has a narrow therapeutic window so that slightly changes in the treatment doseco...
Levothyroxine (LT4) has a narrow therapeutic window so that slightly changes in the treatment doseco...
Levothyroxine (LT4) has a narrow therapeutic window so that slightly changes in the treatment doseco...
Objective The aim was to evaluate if bariatric surgery can affect the LT4 performance. The endpoints...
Background: The absorption of levothyroxine (LT4) is affected by many factors. Bariatric surgery is ...
BACKGROUND: The aim of this study was to evaluate the effect of bariatric surgery on the defined dai...
BACKGROUND: The aim of this study was to evaluate the effect of bariatric surgery on the defined dai...
BACKGROUND: The aim of this study was to evaluate the effect of bariatric surgery on the defined dai...
BACKGROUND: The aim of this study was to evaluate the effect of bariatric surgery on the defined dai...
BACKGROUND: The aim of this study was to evaluate the effect of bariatric surgery on the defined dai...
Objective: Levothyroxine (LT4) is used by almost 13 million patients in USA and in the same country ...
The most common endocrine disease in obesity is hypothyroidism and secondary endocrine alterations, ...
Aim: Levothyroxine (L-T4) requirements in obese hypothyroid patients receiving L-T4 therapy decrease...
The most frequent endocrine disease in obese patients is hypothyroidism. To date, there are no clear...
Aim: Levothyroxine (L-T4) requirements in obese hypothyroid patients receiving L-T4 therapy decrease...
Levothyroxine (LT4) has a narrow therapeutic window so that slightly changes in the treatment doseco...
Levothyroxine (LT4) has a narrow therapeutic window so that slightly changes in the treatment doseco...
Levothyroxine (LT4) has a narrow therapeutic window so that slightly changes in the treatment doseco...
Objective The aim was to evaluate if bariatric surgery can affect the LT4 performance. The endpoints...
Background: The absorption of levothyroxine (LT4) is affected by many factors. Bariatric surgery is ...
BACKGROUND: The aim of this study was to evaluate the effect of bariatric surgery on the defined dai...
BACKGROUND: The aim of this study was to evaluate the effect of bariatric surgery on the defined dai...
BACKGROUND: The aim of this study was to evaluate the effect of bariatric surgery on the defined dai...
BACKGROUND: The aim of this study was to evaluate the effect of bariatric surgery on the defined dai...
BACKGROUND: The aim of this study was to evaluate the effect of bariatric surgery on the defined dai...
Objective: Levothyroxine (LT4) is used by almost 13 million patients in USA and in the same country ...
The most common endocrine disease in obesity is hypothyroidism and secondary endocrine alterations, ...